What is the best management for a local recurrence for a stage I NSCLC treated previously with SBRT?

There is little data to guide management in this scenario given high rates of local control with SBRT and a relatively frail patient population at risk for intercurrent death, reducing the number of patients at risk for local failure.

Given the lack of data, utilization of first principles and a bit...